VXRT - Vaxart gets BARDA funding for Phase 2 study of COVID-19 pill vaccine
2024-01-19 11:15:59 ET
More on Vaxart
- Vaxart, Inc. (VXRT) Q3 2023 Earnings Call Transcript
- Vaxart announces $10M equity offering, key person steps down
- Vaxart Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Vaxart
- Historical earnings data for Vaxart
For further details see:
Vaxart gets BARDA funding for Phase 2 study of COVID-19 pill vaccine